SEP 4, 2026 · PHASE EARLY PHASE 1 TRIAL
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
ClinicalTrials.gov
Early-phase pilot study with no results yet reported; designed to assess safety and feasibility of psilocybin in a cognitively vulnerable population.
Reported
Estimated enrollment20
PhaseEARLY_PHASE1
Primary outcome measureChange in Cornell Scale for Depression in D…